NUMSAS: are you claiming correctly?

NUMSAS: are you claiming correctly?

April 25, 2019

Following the extension of the NHS Urgent Medicine Supply Advanced Service (NUMSAS) pilot until September 30th 2019, community pharmacy contractors are reminded of the need to follow the correct process when claiming for payment.

Contractors may find PSNC Briefing 034/17 useful when claiming for payment as it contains a checklist for completing an FP10DT EPS dispensing token after each NUMSAS referral and a checklist for submitting the tokens and claim form at the end of the month.

Claiming for quantities

When completing the FP10DT EPS token, contractors should be aware that quantities claimed for are linked to the Dictionary of medicines and devices (dm+d) tool. The dm+d quantities are based upon the number of doses, for example, a salbutamol inhaler should be recorded on the FP10DT EPS dispensing token as 200 for 200 doses, not 1 for an original pack.

Incorrect quantities recorded on the FP10DT EPS dispensing token will lead to incorrect payments.

The NUMSAS guide highlights the following examples of the correct way to claim for quantities:

Form Record on dm+d Example
Creams Per gram supplied

Betnovate cream 30g

Record quantity as 30

Tablets and capsules Per tablet/capsule

Bisoprolol 10mg tablets x 7

Record quantity as 7

Liquids (including eye drops) Per ml

Epilim liquid 200mg/5ml 70ml

Record quantity as 70

Devices Per device

Aerochamber Plus with infant face mask

Record quantity as 1

Inhalers Per dose

Salbutamol inhaler 200 doses x 1 original pack

Record as 200

Submitting NUMSAS tokens to NHSBSA

NHSBSA has issued the following advice to contractors:

  • Before sealing the envelope, steps should be taken to ensure that there is a completed submission form, including a signature, as well as tokens relating to each referral.
  • A completed token is required even if no item has been dispensed. This should have full details of what was requested and the patient’s GP, so that a full picture of medicines requested can be made.
  • Claims should relate to a single month only. Where more than one month is sent, these should be separated, and a submission form completed for each month. Only one submission form is required per monthly claim.
  • Any additional information relating to the service i.e. NHS111 referral information is not required for processing claims, therefore should not be included within your claim submission.
  • To help with the preparation processes, please refrain from stapling forms or tokens and the attachment of sticky labels or post-it notes where possible.

Contractors should place the completed NUMSAS claim form along with the completed FP10DT EPS dispensing tokens (completed as part of the NUMSAS) in an envelope clearly marked ‘NUMSAS’; and send the NUMSAS envelope to the NHSBSA with the normal monthly submission bundle.

Please note, if the above process is not followed, a delay in processing and payment may occur.

Gabapentin and pregabalin requests

As pharmacists will be aware, gabapentin and pregabalin were reclassified as Schedule 3 Controlled Drugs (CDs) on 1st April 2019. An emergency supply of these medicines via NUMSAS is therefore not permitted.

Pharmacists may receive requests for CDs as call advisors in NHS 111 call centres, handling the request for urgent medicines supplies, are non-clinical members of staff and do not have conversations with patients about the medicine(s) they need.

Pharmacists should support and escalate these patients appropriately if they urgently require a CD; the process to follow is outlined in the NUMSAS service specification (section 3.2.2).

Contractors are reminded that they can still claim payment for these referrals even though a supply cannot be made. Contractors should complete an FP10DT EPS as stated in section 3.6.2 of the service specification and include the reason for not supplying, using the standard no-supply code as detailed below:

Reason supply was not made Standard No-Supply Code to be endorsed on FP10DT
Item not able to be supplied under emergency supply regulations (e.g. Schedule 1. 2 or 3 Controlled Drug) NoSupp A

Further information on NUMSAS can be found at:

Posted in: ,

More Latest News >